Skip to main content

Table 4 Univariate analysis predicting 30-day mortality

From: Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction

 

HR (95% CI)

P value

Patient characteristics

  

Age, per 10 years

1.638 (1.174-2.285)

0.004

EF, per 5%

1.061 (0.887-1.269)

0.516

Left main

2.143 (0.504-9.117)

0.302

STEMI

1.005 (0.479-2.108)

0.989

Mechanical ventilation

1.313 (0.625-2.762)

0.472

Hemodynamics and catecholamines

  

CO, L/min

0.986 (0.760-1.279)

0.915

CI, L/min/m2

0.934 (0.594-1.468)

0.768

CPI, 0.1 W/m2

0.766 (0.593-0.991)

0.043

CPO, 0.1 W

0.874 (0.747-1.023)

0.094

Microcirculatory PI/10

0.888 (0.795-0.992)

0.036

SVRI, 100 dynes sec/cm5/m2

0.992 (0.937-1.050)

0.776

MAP, 5 mm Hg

0.821 (90.726-0.928)

0.002

Heart rate, 5 beats/min

1.086 (1.003-1.176)

0.041

Catecholamine use

3.073 (0.716-13.198)

0.131

Total number of catecholamines

2.332 (1.350-4.029)

0.002

Mean dose of catecholamines, 10 µg/min

1.014 (1.004-1.024)

0.006

Organ failure

  

Acute kidney injury

5.084 (2.290-11.290)

<0.0001

SIRS

1,412 (0.639-3.121)

0.394

MOF

8.317 (3.754-18.425)

<0.0001

Lactate, mM

1.164 (1.086-1.247)

<0.0001

APACHE II > Median

2.390 (0.908-6.294)

0.078

Laboratory measurements

  

Creatinine T0, mg/dl

1.299 (1.092-1.546)

0.003

Creatinine T1, mg/dl

2.155 (1.534-3.028)

<0.0001

Creatinine T2, mg/dl

1.562 (0.626-3.901)

0.339

Nt-proBNP T0, 1,000 pg/ml

1.022 (0.988-1.056)

0.204

Nt-proBNP T1, 1,000 pg/ml

1.111 (1.045-1.182)

0.001

Nt-proBNP T2, 1,000 pg/ml

1.109 (0.959-1.282)

0.161

IL-6 T0, 100 pg/ml

1.019 (1.008/1.030)

0.001

IL-6 T1, 100 pg/ml

1.134 (1.023-1.257)

0.016

Il-6 T2, 100 pg/ml

1.550 (1.031-2.331)

0.035

PCT T0, µg/L

1.368 (1.075-1.741)

0.011

PCT T1, µg/L

1.266 (1.122-1.429)

<0.0001

PCT T2, µg/L

2.980 (1.687-5.265)

<0.0001

  1. IL-6, interleukin-6; MOF, multiorgan failure; Nt-proBNP, N-terminal pro-B-type natriuretic peptide; PCT, procalcitonin; SIRS, systemic inflammatory response syndrome; other abbreviations as in Tables 1 through 3.